These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 2657280)
1. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease. May B Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280 [TBL] [Abstract][Full Text] [Related]
2. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate. Bianchi Porro G; Parente F J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753 [TBL] [Abstract][Full Text] [Related]
3. Medical treatment of peptic ulcers. Deveney CW; Deveney KE Surg Annu; 1985; 17():219-33. PubMed ID: 3883541 [TBL] [Abstract][Full Text] [Related]
4. Drugs for treatment of peptic ulcers. Dajani EZ; Trotman BW J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999 [TBL] [Abstract][Full Text] [Related]
5. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease. Tytgat GN; Nio CY Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of peptic ulcer and chronic gastritis with bismuth salts]. Rösch W Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
8. Treatment of the gastric stump ulcer: an open study with five drugs. Janke A; Stasiewicz J; Namiot Z; Szalaj W Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913 [TBL] [Abstract][Full Text] [Related]
9. Current trends in the pharmacotherapy for peptic ulcer disease. Hixson LJ; Kelley CL; Jones WN; Tuohy CD Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429 [TBL] [Abstract][Full Text] [Related]
10. Overview of medical therapy of peptic ulcer disease. Freston JW Gastroenterol Clin North Am; 1990 Mar; 19(1):121-40. PubMed ID: 2184124 [TBL] [Abstract][Full Text] [Related]
11. Role of protective drugs in the prevention of ulcer relapse. Ota S; Terano A J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147 [TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. Dajani EZ; Agrawal NM J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335 [TBL] [Abstract][Full Text] [Related]
13. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Wagstaff AJ; Benfield P; Monk JP Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124 [TBL] [Abstract][Full Text] [Related]
14. Effects of cigarette smoking on duodenal ulcer healing and relapse rate. Boonyapisit S; Manatsathit S; Kachintorn U; Tanwandee T; Sattawatthamrong Y; Chinapak O J Med Assoc Thai; 1994 Nov; 77(11):566-71. PubMed ID: 7759964 [TBL] [Abstract][Full Text] [Related]
15. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465 [TBL] [Abstract][Full Text] [Related]